Brain dopamine transporter in spontaneously hypertensive rats

Journal of Nuclear Medicine

Volumn 38, Issue 3, 1997, Pages 470-474

  Watanabe, Yoshiyuki ^a   Fujita, Masahiro ^a   Ito, Yasushi ^a   Okada, Tomoya ^a   Kusuoka, Hideo ^a   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Dopamine receptor; Dopamine transporter; Hypertension; Iodine 125 CIT

Indexed keywords

2,3,4,5 TETRAHYDRO 8 IODO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; IODOSPIPERONE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR BINDING; SPONTANEOUSLY HYPERTENSIVE RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN CHEMISTRY; CARRIER PROTEINS; CAUDATE NUCLEUS; COCAINE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HYPERTENSION; IMAGE ENHANCEMENT; IODINE RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PUTAMEN; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, DOPAMINE; SPIPERONE;

EID: 0030885047     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Buuse MV, Versteeg DHG, Jong WD. Brain dopamine depletion by lesion in the substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat. Brain Res 1986;368:69-78.
2. Linthorst ACE, Giersbergen PLM, Gras M, Versteeg DHG, Jong WD. The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rat. Brain Res 1994;639:261-268.
3. Nagaoka A, Lovenberg W. Regional changes in the activities of aminergic biosynthetic enzymes in the brains of hypertensive rats. Eur J Pharmacol 1977;43:297-306.
4. Howes LG, Rowe PR, Summers RL, Louis WJ. Age-related changes of cat-echolamines and their metabolites in central nervous system regions of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Clin Exp Hypert 1984;A6:2263-2277.
5. McKeon TW, Hendly ED. Brain monoamines and metabolites in hypertensive and hyperactive rat strains. Clin Exp Hypert 1988;A10:971-994.
6. Yamori Y. Development of the spontaneously hypertensive rat and of various spontaneous rat models and their implications. In: Jong WD, ed. Handbook of hvpertension: experimental and genetic model of hypertension, vol.4. Amsterdam, The Netherlands: Elsevier Science; 1984:224-239.
7. Stumpe KO, Kolloch R, Higuchi M, Kruck F, Vetter H. Hyperproloctinemia, antihypertensive effect of bromocriptine in essential hypertension. Lancet 1977:211-214.
8. Sowers JR. Effect of bromocriptine on responses to stress in spontaneously hypertensive rats. Hypertension 1981;3:544-550.
9. 125I]RTI-55. J Chem Neuroanat 1994;7:13-23.
10. Dawson TM, Barone P, Sidhu A, Wamsley JK, Chase TN. The D1 dopamine receptors in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience 1988;26:83-100.
11. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego, CA: Academic Press: 1986.
12. Okamoto K, Aoki K. Development of a strain of spontaneous hypertensive rats. Jpn Circ J 1963;27:282-293.
13. Trippodo NC, Frohlich ED. Similarities of genetic hypertension; man and rat. Circ Res 1981;48:309-319.
14. Kujirai K, Przendborski S, Kostic V, et al. Autoradiography of dopamine receptors and dopamine uptake sites in the spontaneously hypertensive rat. Brain Res Bull 1990;25: 703-709.
15. Graybiel AM, Moratalla R. Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartment. Proc Natl Acad Sci USA 1989;86:9020-9024.
16. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 1992;12:27-36.
17. 125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography. Synapse 1992;12:37-46.
18. 3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol Pharmacol 1984;26:35-44.
19. Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ. The pre-, postnatal development of the dopaminergic cell groups in the ventral mesencephalon of the striatum of the rat. Neuroscience 1988;25:857-887.
20. Bayer SA. Neurogenesis in the rat striatum. Int J Devl Neuroscience 1984;2:163-175.
21. Kirouac GJ, Ganguly PK. Up-regulation of dopamine receptors in the brain of the spontaneous hypertensive rat: an autoradiography analysis. Neuroscience 1993;52: 135-141.
22. Lim DK, Ito Y, Hoskins B, Rockhold RW, Ho IK. Comparative studies of muscarinic and dopamine receptors in three strains of rat. Eur J Pharmacol 1989;165:279-287.
23. Lim DK, Yu ZJ, Hoskins B, Rockhoid RW, Ho IK. Effect of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: 2 dopamine receptors. Neurochem Res 1990;15:621-627.
24. Watanabe M, Tsuruta S, Inoue Y, et al. Dopamine D1 and D2 receptors in spontaneously hypertensive rat brain striatum. Can J Physiol Phamacol 1989;67: 1596-1597.
25. Linthorst ACE, Jong WD, Boer TD, Versteeg DHG. Dopamine D1 and D2 receptors in the caudate nucleus of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats. Brain Res 1993;602:119-125.
26. Buuse MV, Jones R, Wagner J. Brain dopamine D2 receptor mechanisms in spontaneously hypertensive rats. Brain Res Bull 1992;28:289-297.
27. Versteeg DHG, Petty MA, Bonus B. The central nervous system and hypertension: the role of catechoamines and neuropeptides. In: Jong WD, ed. Handbook of hypertension: experimental and genetic model of hypertension, vol. 4. Amsterdam, The Netherlands: Elsevier Science;1984:398-430.
28. 125I]RTI-55. Synapse 1992;12:99-111.
29. 125I]RTI-55: in vitro binding and autoradiographic characterization. J Neurochem 1994;62:549-556.
30. Seibyl JP, Wallace E, Smith EO, et al. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-β-CIT in healthy human subjects J Nucl Med 1994;35:764-770.
31. Kuikka JT, Bergstrom KA, Ahonen A, Lansimies E. The dosimetry of iodine-123-labeled 2β-carbomethoxy-3β-(4-iodophenyl)tropane. Eur J Nucl Med 1994;21:53-56.
32. Innis RB. Single-photon emission tomography imaging of dopamine terminal innervation: a potential clinical tool in Parkinson's disease. Eur J Nucl Med 1994;21:1-5.
33. Seibyl JP, Laruelle M, Dyck CH, et al. Reproducibility of iodine-123-β-CIT SPECT brain measurement of dopamine transporters. J Nucl Med 1996;37:222-228.
34. 123I]beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 1994;14:982-994.
35. Dyck CH, Seibyl JP, Malison RT, et al. Age-related decline in striatal dopamine transporter binding with iodine-123-β-CIT SPECT. J Nucl Med 1995;36: 1175-1181.